http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2413883-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec6f9b9e350cbc18ac49f1d6cb627796 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2000-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05436ae71d0b24e98290f0f7bbff1470 |
| publicationDate | 2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2413883-C |
| titleOfInvention | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
| abstract | A method for preventing tissue damage associated with graft-versus-host disease in a patient having undergone hematopoietic cell transplantation, an d host-versus-graft disease in a patient having undergone organ allograft transplantation. The method includes orally administering to the patient a prophylactically effective amount of a topically active corticosteroid, such as beclomethasone dipropionate, for a period of time following hematopoietic cell or organ allograft transplantation, and prior to the presentation of symptoms associated with graft-versus-host disease or host-versus-graft disease. Representative tissues includes tissue of the intestine and liver, while representative tissue damage includes inflammation thereof. |
| priorityDate | 2000-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.